Last updated: 2026-09-08 05:59:20. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Canton Strategic Holdings, Inc. (CNTN) operates in the FINANCE SERVICES sector and is listed on NASDAQ. The stock is currently priced at $2.29, with a market capitalization of $181.67M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $1.75 to $5.27. This page covers its latest market performance, valuation, price trends and company information.
$181.67M | |
$2.21 | |
$5.27 | |
$1.75 | |
$2.25 | |
383.79K | |
916.37K | |
-- | |
$5.27 | |
$1.75 | |
-- | |
-- |
Canton Strategic Holdings, Inc. (CNTN) last closed at $2.25 as of 2026-09-04 23:50:00, unchanged from the previous close of $2.25.
During the latest regular trading session, CNTN traded between $1.75 and $5.27, with a volume of 383.79K shares. The closing price was near the lower end and near the lower end of its 52-week range.
Over the past seven days, Canton Strategic Holdings, Inc. (CNTN) moved from $2.35 to $2.29, representing a decline of 2.77% ($0.06).
The stock traded between $2.04 and $2.40 during the period. The latest price is near the upper end of the 7-day range, indicating moderate downward.
The average daily volume was 524.36 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 15.2%
CNTN is currently trading at $2.29, placing it 15.2% of the way from its 52-week low of $1.75 to its 52-week high of $5.27. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Canton Strategic Holdings Inc is engaged in activities related to Canton Network, including the use of Canton Coin, to support blockchain-based infrastructure and the digitization of financial market processes. The company operates in two reportable segments: digital asset treasury and clinical stage bio-technology. Its flagship clinical asset, GV104, is being developed for a specific indication for respiratory and/or nervous system depression in military personnel and chemical incident responders. The expanded pipeline includes other indications for GV104 and GV023, an approach to autoimmune diseases as well as an early-stage multispecific biologic platform.
| Industry | FINANCE SERVICES |
| Employees | 12 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Canton Strategic Holdings, Inc. (CNTN) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.